These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31074017)

  • 1. A series of 33 older patients with lip venous lake treated by sclerotherapy.
    Fernandes DT; Hebling E; Santos-Silva AR; Lopes MA
    Int J Dermatol; 2020 Jan; 59(1):42-46. PubMed ID: 31074017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: A retrospective study of 43 patients.
    Fernandes DT; Elias RA; Santos-Silva AR; Vargas PA; Lopes MA
    Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e180-e187. PubMed ID: 29476682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Lakes of the Lips Successfully Treated With a Sclerosing Agent 1% polidocanol: analysis of 25 report cases.
    Cebeci D; Karasel S; Yaşar Ş
    Int J Surg Case Rep; 2021 Jan; 78():265-269. PubMed ID: 33373920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.
    Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
    J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous lake of the lip treated with a sclerosing agent: report of two cases.
    Kuo HW; Yang CH
    Dermatol Surg; 2003 Apr; 29(4):425-8. PubMed ID: 12656828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases.
    Hoque S; Das BK
    Pediatr Surg Int; 2011 May; 27(5):527-31. PubMed ID: 21290138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of 0.5% Sodium Tetradecyl Sulfate on a Venous Lake Lesion.
    Jung SJ; Seo YJ; Park EJ; Kim CW; Cho HJ; Kim KH; Kim KJ
    Ann Dermatol; 2008 Dec; 20(4):179-83. PubMed ID: 27303187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sclerotherapy of benign oral vascular lesions with monoethanolamine oleate.
    da Silva Barros CC; Campos CM; de Morais Medeiros HC; Queiroz LMG; da Silveira ÉJD
    Clin Oral Investig; 2021 Apr; 25(4):1767-1774. PubMed ID: 32748074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.
    Choi YH; Han MH; O-Ki K; Cha SH; Chang KH
    J Vasc Interv Radiol; 2002 May; 13(5):475-82. PubMed ID: 11997355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoethanolamine oleate sclerotherapy for the treatment of intraoral vascular anomalies: retrospective study and suggestion for a clinical guideline.
    Tolentino ES; Faria LO; Vargas RM; Camarini C; Santin GC; Chicarelli da Silva M
    Br J Oral Maxillofac Surg; 2020 May; 58(4):416-420. PubMed ID: 32057469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
    Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
    J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of venous malformations with ethanolamine oleate.
    Das BK; Hoque S
    Asian J Surg; 2008 Oct; 31(4):220-4. PubMed ID: 19010768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy as an esthetic indication in oral vascular malformations: a case series.
    Manzano BR; Premoli AM; Santaella NG; Ikuta CRS; Rubira CMF; Santos PSDS
    An Bras Dermatol; 2019; 94(5):521-526. PubMed ID: 31777351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
    Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy of Vascular Malformations in the Oral Cavity-Minimizing Postoperative Morbidity.
    Zeevi I; Chaushu G; Alterman M; Chaushu L
    Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32456057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with 5% ethanolamine oleate for sclerotherapy of oral vascular anomalies: A cohort of 15 consecutive patients.
    Kato CNAO; Ribeiro MC; do Amaral MBF; Grossmann SMC; de Aguiar MCF; Mesquita RA
    J Craniomaxillofac Surg; 2019 Jan; 47(1):106-111. PubMed ID: 30527382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute ethanol and 5% ethanolamine oleate are comparable for sclerotherapy of esophageal varices.
    Meirelles-Santos JO; Carvalho AF; Callejas-Neto F; Magna LA; Yamanaka A; Zeitune JM; Brandalise NA; Ferraz JG
    Gastrointest Endosc; 2000 May; 51(5):573-6. PubMed ID: 10805844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound follow-up of ethanolamine oleate sclerotherapy for spermatoceles.
    Mattila SI; Tammela TL; Mäkäräinen HP; Hellström PA
    Eur Urol; 1993; 23(3):361-5. PubMed ID: 8508888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of venous lesions of the lips and perioral area with a long-pulsed Nd:YAG laser.
    John HE; Phen HS; Mahaffey PJ
    Br J Oral Maxillofac Surg; 2016 May; 54(4):376-8. PubMed ID: 26233280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients.
    Gelbert F; Enjolras O; Deffrenne D; Aymard A; Mounayer C; Merland JJ
    Neuroradiology; 2000 Sep; 42(9):692-6. PubMed ID: 11071446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.